[Clinical use of gamma-aminobutyric acid derivatives in experimental and clinical psychiatry and neurology (review of the literature)].
D000613:Aminobutyrates / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D002794:Choline / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006885:Hydroxybutyrates / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D000860:Hypoxia / Q000150:complications; D001523:Mental Disorders / Q000188:drug therapy; D051379:Mice; D009422:Nervous System Diseases / Q000188:drug therapy; D010100:Oxygen; D011600:Psychopharmacology; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy; D013016:Sound; D013331:Strychnine
D000613:Aminobutyrates; D006885:Hydroxybutyrates; D013331:Strychnine; D002794:Choline; D010100:Oxygen
Klinicheskoe primenebnie proizvodnykh gamma-aminomaslianoĭ kisloty v èksperimental'noĭ i klinicheskoĭ psikhiatrii i i nevrologii (obzor literatury.